🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06892938
Active, not recruiting Observational

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

NCT06892938 · tracked via the Priya Life Science USA tracker
Sponsor
Everbeat
Phase
Observational
Started
2024-09-17
Last updated
2025-03-27

Condition(s) studied

Atrial Fibrillation (AF)Arrhythmias CardiacTachycardiaPalpitationsBradycardia

Investigational drug(s) / intervention(s)

Atrial Fibrillation Identification

Atrial Fibrillation Identification: Identification of atrial fibrillation by device.

Study summary

Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 18 years of age or older Exclusion Criteria: * Presence of pacemaker or defibrillator * Inability to wear a ring in size range available

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
XIMED La Jolla California
Our Lady of Lake Hospital Baton Rouge Louisiana
Allegheny General Hospital Pittsburgh Pennsylvania

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06892938 on ClinicalTrials.gov ↗ ← All trials in the USA